Levolta Pharmaceuticals Competitors and Similar CompaniesClear all
Levolta Pharmaceuticals's competitors and similar companies include Agios Pharmaceuticals, Helsinn Group, TriSalus Life Sciences and CHUGAI PHARMA FRANCE.
 Levolta Pharmaceuticals Levolta Pharmaceuticals is a pharmaceutical company focused on the acquisition, development, and commercialization of products for the treatment of rheumatology, immunology and cancer. |  Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism. |  Helsinn Group Helsinn Group is a pharmaceutical company that focuses on therapeutic and supportive care products for cancer. |  TriSalus Life Sciences TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors. | ||
Founding Date | Founding Date 2013 | Founding Date 2008 | Founding Date 1976 | Founding Date 2009 | Founding Date 1998 |
Type | Type Private | Type Public | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Bethlehem, US HQ | Locations Cambridge, US HQ | Locations Pazzallo, CH HQ Shanghai, CN Monaco, MC Biasca, CH Woodbridge Township, US | Locations Westminster, US HQ Bannockburn, US Cranston, US | Locations Paris, FR HQ |
Employees | Employees 3 | Employees 53611% increase | Employees 3731% decrease | Employees 106 | Employees 73 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) N/A | Valuation ($) 117.2 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $54m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $45.2m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $6.3m (FY, 2025) | Cost of goods N/A | Cost of goods $7m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $47.7m (FY, 2025) | Gross profit N/A | Gross profit $38.2m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($412.8m) (FY, 2025) | Net income N/A | Net income ($39.2m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Agios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
View companyHelsinn Group
HQ
Pazzallo, CH
Employees
373↓ 1% decrease
Helsinn Group is a pharmaceutical company that focuses on therapeutic and supportive care products for cancer.
View companyTriSalus Life Sciences
HQ
Westminster, US
Employees
106
TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors.
View company
CHUGAI PHARMA FRANCE
HQ
Paris, FR
CHUGAI PHARMA FRANCE is a company that specializes in pharmaceutical products.
View company